Sopino, Vicente C.

HRN: 11-26-24  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/08/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/08/2022
11/19/2022
IV
1.5g
Q6
Infected Wound L Foot
Waiting Final Action 
11/08/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/08/2022
11/15/2022
IV
600mg
Q8
Infected Would L Foot
Waiting Final Action 
11/15/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/15/2022
11/25/2022
IVT
1.5 G Ivt
Q6 X 4 Days More
Nonhealing Wound, Multiple Myeloma
Waiting Final Action 
11/15/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/15/2022
11/25/2022
IVT
600mg
Q8 For 4 Days More
Nonhealing Wound, Multiple Myeloma
Waiting Final Action 
02/05/2023
CEFTAZIDIME 1GM (VIAL)
02/05/2023
02/12/2023
IV
2g
Q8
HAP
Waiting Final Action 
02/05/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/05/2023
02/12/2023
IV
600mg
Q8
HAP
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: